S. Rajappa, Tetrahedron, 37: 1453 (1981). |
H. Dabrowska-Urbanska et al., Tetrahedron, 25: 1617 (1969). |
C. M. Baltzer et al., J. Org. Chem., 38: 155 (1973). |
F. Eloy et al., Chem. Revs., 62: 155 (1962). |
The Chemistry of Amidines and Imidates, edited by S. Patai, John Wiley & Sons, pp. 438-439 (1975). |
E. L. Schumann et al., J. Med. Pharm. Chem., 5: 464 (1962). |
M. C. Seidel et al., J. Heterocyclic Chem., 9: 231 (1972). |
Chem. Abst., 32: 13754a (1962). |
G. W. Raiziss et al., J. Am. Chem. Soc., 63: 3124 (1941). |
Chem. Abst., 108: 38245v (1988). |
A. F. McKay et al., J. Am. Chem. Soc., 70: 430 (1948). |
D. C. Baker et al., Synthesis, 1978, p. 478. |
Chem. Abst., 70: 12646y (1969). |
H. Petersen et al., Synthesis, 1973, p. 243. |
H. Hellmann et al., α-Aminoalkylierung, Verlag Chemie GmbH, 1960, pp. 66-69, 304-305, 308-309 and 334-335. |
Y. Yongzhong et al., Propellants, Explosives, Pyrotechnics, 14: 150 (1989). |
M. Takimoto et al., Bull. Chem. Soc. Jpn., 56: 3319 (1983). |
M. Yokoyama et al., J. Chem. Soc. Perkin Trans. I, pp. 2309-2313 (1988). |
L. Wittenbrook et al., J. Org. Chem., 88: 465 (1973). |
D. Trepanier et al., J. Med. Chem., 12: 257 (1969). |
J. Michels et al., J. Am. Chem. Soc., 78: 5349 (1956). |
A. McKay et al., Can. J. Chem., 38: 343 (1960). |
J.M. Lehn et al., Helv. Chim. Acta, 59: 1566 (1976). |
H. Kunzi et al., Helv. Chim. Acta, 57: 566 (1974). |
R. Khomutov et al., Bull. Acad. Sci., USSR Div. Chem. Sci. 1006 (1962). |
L. Fishbein et al., J. Am. Chem. Soc., 76: 1877 (1954). |
L. Bauer et al., J. Org. Chem., 30: 949 (1965). |
S. Soloway et al., Advances and Pesticides Science, Fourth International Congress of Pesticide Chemistry, Zurich, Switzerland, Jul. 22-28, 1978, part 2, pp. 206-217. |
K. Jensen et al., Acta Chem. Scand., 21: 2797 (1967). |
E. Bissell et al., Tetrahedron, 26: 5737 (1970). |
K. Mayer et al., Synthesis, pp. 370-372 (1971). |
Chem. Abst., 56: 14080b (1962). |
H. Showalter et al., J. Het. Chem., 23: 1491 (1986). |
C. Grundmann et al., Chem. Ber., 91: 1766 (1958). |
E. Muller, Houben Weyl, Auflage, Bd. 10/2, Thieme Verlag, Stuttgart, 1967, pp. 58-59. |
B. Heitke et al., J. Org. Chem., 39: 1522 (1974). |
M. Pankaskie et al., Synthetic Communications, 19: 339 (1989). |
E. Pfeil et al., Angew. Chem., 79: 188 (1967). |
W.A. Jacobs et al., J. Biol. Chem., 21: 403 (1915). |
J. Korosi et al., Chem. Ber., 101: 1979 (1968). |
J. Sequin et al., Bull. Soc. Chim. Fr., pp. 1210-1212 (1956). |
R. Khomutov et al., Izv. Akad. Nauk SSSR, Otd. Khim. Nauk, No. 1-6, pp. 1074-1076 (1962). |
W. Best et al., Aust. J. Chem., 43: 427 (1990). |
A. Khomutov et al., Bioorg. Khim., 12: 1662 (1986). |
E. Schumann et al., J. Med. Chem., 7: 329 (1964). |
W. Moore et al., J. Med. Chem., 39: 669 (1996). |
A. Schoberl et al., Liebigs Ann., 614: 83 (1958). |
T. Caronna et al., Tetrahedron, 33: 793 (1977). |
L. Bauer et al., J. Org. Chem., 30: 4298 (1965). |
S. Rajappa et al., Helv. Chim. Acta, 67: 1669 (1984). |
J. March, Advanced Organic Chemistry, John Wiley & Sons, New York, 1985, p. 324. |
A. Nielsen, The Chemistry of the Nitro and Nitroso Groups, Part 1, Ed. H. Feuer, Interscience Publishers, New York, 1969, pp. 417-453. |
C. McCarty, The Chemistry of the Carbon Nitrogen Double Bond, Ed. S. Patai, Interscience Publishers, New York, 1970, pp. 386-388. |
H. Kalinowski et al., 13C-NMR-Spektroskopie, Thieme Verlag, Stuttgart, 1984, pp. 457-458. |
P. Vieles et al., Bull. Soc. Chim. Fr., 1953, pp. 287-289. |
T. Tidwell, Synthesis, 1990, pp. 857-870. |
S. Ley et al., Synthesis, 1994, pp. 639-666. |
A. Vogel et al., J. Chem. Soc., 1952, pp. 514-549. |
V. Khilya et al., Chemistry of Heterocyclic Compounds, 3: 815, 1967. |
K. Jones et al., Tetrahedron, 52: 4133 (1996). |
R. Huffmann et al., J. Org. Chem., 28: 1816 (1963). |
A. Rougny et al., Bull. Soc. Chim. Fr., 1976, 5-6, pp. 833-838. |
J. Bompart et al., Eur. J. Med. Chem., 23: 457 (1988). |
W. Lossen, Liebigs Ann. Chem., 1889, pp. 170-240. |
B. Klieser et al., Kontakte, 1984 (1), pp. 3-17. |
J. Lown et al., J. Org. Chem., 47: 2027 (1982). |
D. Keirs et al., J. Chem. Soc., Chem. Commun., 1987, pp. 1660-1661. |
Methoden der Organischen Chemie, 1971, Georg Thieme Verlag, Stuttgart, pp. 468, 469, 757, 756, 764-766 and 789. |
Methoden der Organischen Chemie, 1958, Georg Thieme Verlag, Stuttgart, pp. 99-106, 110-117 and 767. |
L. Hafner et al., J. Org. Chem., 24: 1157 (1959). |
L. Wittenbrook et al., J. Org. Chem., 38: 465 (1973). |
C.G. McCarty et al., J. Org. Chem., 35: 2067 (1970). |
L.H. Diamond et al., J. Am. Chem. Soc., 77: 3131 (1955). |
A.F. McKay et al., Can. J. Chem., 38: 343 (1960). |
J. Lehn et al., Hely. Chim. Acta, 59: 1566 (1976). |
H. Kunzi et al., Hely. Chim. Acta, 57: 566 (1974). |
E. R. Bissell et al., Tetrahedron, 26: 5737 (1970). |
W.D. Habicher et al., Z. Chem., 8: 459 (1968). |
T. Nambara et al., J. Chromatogr. 1976, 118, 127-133. |
P. Maienfisch, L. Gsell und a Rindlisbacher, Synthesis and Insecticidal Activity of CGA 293343 a Novel Broad Spectrum Insecticide; IUPAC Congress London 1998. |
Civil Action 98-996-C-M2/Plaintiff Bayer Complaint and Jury Demand, 1998. |
AGROW, 06.09.99: Thiamethoxam Patent Dispute, 1999. |
May 20, 1999 decision of the Opposition Division of the European Patent Office on applicants' European Patent No. 386565 (Filed as Exhibit A with third Preliminary Amendment), 1999. |
Oct. 7, 1998 Declaration of Professor Jack Baldwin Pertaining to European Patent EP 386 565 (Filed as Exhibit D with third Preliminary Amendment), 1998. |
English translation of transmittal letters, demand for trial to invalidate Japanese Patent No. 2,961,516, and supporting brief, dated Nov. 17, 2000, filed by Novartis AG. |
Transmittal letters, demand for trial to invalidate Japanese Patent No. 2,961,516, and supporting brief, dated Nov. 17, 2000, filed by Novartis AG (In Japanese). |
Letter dated Nov. 18, 1998 from applicants' European Counsel submitting response to Giese Report in Opposition Proceeding to European Patent 386 565 (Filed as part of Exhibit D with third Preliminary Amendment). |
English Translation of Annex 11, Sep. 1998 Report of Dr. Bernd Giese filed by Novartis in Opposition Proceeding to European Patent 386 565 (Filed as part of Exhibit D with third Preliminary Amendment). |
Written Comments of Professor Jack Baldwin, dated Nov. 16, 1998, to Sep. 1998 Report of Dr. Bernd Giese filed by Novartis in Opposition Proceeding to European Patent 386 565 (Filed as part of Exhibit D with third Preliminary Amendment). |
Cover letter from European Patent Office dated Oct. 13, 1999, forwarding Novartis's Appeal documents from Opposition Proceeding to European Patent 386 565. |
Cover letter from Novartis's European attorneys, Zumstein & Klingseisen, dated Sep. 30, 1999, forwarding for filing in European Patent Office Novartis's Appeal documents from Opposition Proceeding to European Patent 386 565. |
Novartis's Appeal Brief (in German) dated Sep. 30, 1999, filed in European Patent Office from the Appeal of the Opposition Proceeding to European Patent 386 565. |
English Translation of Novartis's Appeal Brief dated Sep. 30, 1999, filed in European Patent Office from the Appeal of the Opposition Proceeding to European Patent 386 565. |
Novartis's list of references, (D-1 to D-93) dated Sep. 30, 1999, cited during opposition Proceeding to European Patent 386 565 and Appeal therefrom. |
Novartis's list of annexes 12-24, dated Sep. 30, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis's Annex 12, A Report Concerning the Contested European Patent No. 386565, by Professor Otto Meth-Cohn, dated Sep. 24, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 13, C.V. of Dr. Otto-Meth-Cohn, dated Sep. 24, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 14, Publication list of Dr. Bernd Giese, dated Sep. 24, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 15, “At the Relevant Date: Were Patent Systems Makable by Patent Methods, (R2 within Z and E other than Alkoxy)” dated Sep. 24, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 16, “At the Relevant Date: Were Precursors of Patent Systems Known,” dated Sep. 24, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 17, “At the Relevant Date: Were Patent Systems Makable by Patent Methods, (At least one R2 within Z and E=Alkoxy)” dated Sep. 24, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 18, Tables of the tested comparison compounds, (in German), dated Sep. 30, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 19, Description of Test Methods, dated Sep. 30, 1999, used for in 1999 “standard” comparison tests summarized in Annex 23, filed with its Appeal from the opposition Proceeding to European Patent 386 565 (In German). |
Translation of Novartis Annex 19, Description of Test Methods, dated Sep. 30, 1999, used for in 1991 “standard” comparison tests summarized in Annex 23, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 20, Description of Test Methods, dated Sep. 30, 1999, used for in 1999 “special” comparison tests summarized in Annex 24, filed with its Appeal from the opposition Proceeding to European Patent 386 565 (In German). |
Novartis Annex 21, Detailed results of “standard” comparison tests, dated Sep. 30, 1999, used to generate summary in Annex 23, filed with its Appeal from the opposition Proceeding to European Patent 386 565 (In German). |
Novartis Annex 22, Detailed results of “special” comparison tests, dated Sep. 30, 1999, used to generate summary in Annex 24, filed with its Appeal from the opposition Proceeding to European Patent 386 565 (In German). |
Novartis Annex 23, Summary results of “standard” comparison tests, dated Sep. 30, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565 (In German). |
Translation of Novartis Annex 23, Summary results of “standard” comparison tests, dated Sep. 30, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565. |
Novartis Annex 24, Summary results of “special” comparison tests, dated Sep. 30, 1999, filed with its Appeal from the opposition Proceeding to European Patent 386 565 (In German). |
Cover letter from European Patent Attorneys for Nihon Bayer Agrochem with enclosures, dated Oct. 23, 2000, forwarding Appeal Brief entitled “Requests, Facts, and Evidence in Support of The Patentability of EP 386 65 B2,” in Appeal No. 750/99-3.3.1, responding to Novartis appeal from opposition proceedings. This Appeal Brief includes exhibits 10-12, 14-21, 23, and 24. |
Cover letter from European Patent Attorneys for Nihon Bayer Agrochem, dated Nov. 21, 2000, forwarding enclosed opinion statement of Professor Jack Baldwin, dated Nov. 7,2000, which is to be designated exhibit 13 to Nihon-Bayer Agrochem's Appeal Brief entitled “Requests, Facts, and Evidence in Support of The Patentability of EP 386 65 B2,” in Appeal No. 750/99-3.3.1, responding to Novartis appeal from opposition proceedings. |
Final Version of Collection of all Experiments submitted by Nihon-Bayer Agrochem's in Appeal No. 750/99-3.3.1, on the production of heterocyclic rings nos 1-36, which is to be designated exhibit 22 to Nihon-Bayer Agrochem's Appeal Brief entitled “Requests, Facts, and Evidence in Support of The Patentability of EP 386 65 B2,” in Appeal No. 750/99-3.3.1, responding to Novartis appeal from opposition proceedings, 2000. |
Preliminarily filed version of Collection of all Experiments submitted by Nihon-Bayer Agrochem's in Appeal No. 750/99-3.3.1, on the production of heterocyclic ring nos 1-36, which is to be designated exhibit 22 to Nihon-Bayer Agrochem's Appeal Brief entitled “Requests, Facts, and Evidence in Support of The Patentability of EP 386 65 B2,” in Appeal No. 750/99-3.3.1, responding to Novartis appeal from opposition proceedings, 2000. |